









Association of Tuberculin Skin Test with Plasma Inflammatory 
Cytokines in Healthy Nigerian Healthcare Workers 
 
 
*Bolajoko E.B.1 and Arinola O.G.2 
1Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria. 
2Department of Immunology, College of Medicine, University of Ibadan, Ibadan, Nigeria. 
  
ABSTRACT 
Tuberculin skin test (TST) is among the screening criterion for tuberculosis and inflammation is known to be associated with 
Mycobacterium tuberculosis infection. Therefore, there is need to investigate the relationship between TST and inflammatory 
cytokines [tumour necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ)] and oxidative stress biomarkers [3-Nitrotyrosine 
(3-NT), inducible nitric oxide synthase (iNOS)] in apparently healthy Nigerian healthcare workers.  
Four millilitres of blood samples were collected from 34 participants for determination of TNF-α, IFN-γ, 3-NT and iNOS using 
ELISA. The TST was performed using 0.1 mL of 5 TU purified protein derivative and the diameter of induration was evaluated 
at 72 hours. Higher levels of TNF-α (10.10±4.31; 11.84±5.81; 12.95±6.96; 14.59±4.71 pg/mL) and IFN-γ (1.30±1.10; 1.44±1.25; 
1.49±1.10; 2.10±1.56 pg/mL) were found at indurations of <5 mm, 5-9 mm, 10-14 mm, ≥15 mm, respectively. However, highest 
levels of 3-NT and iNOS, were found at indurations of 10-14 mm. Tuberculin skin test correlated positively with TNF-α, IFN-γ, 
iNOS (p>0.05) and age (p<0.05), while 3-NT was inversely correlated with TST (p>0.05). Almost half of the healthcare workers 
had indurations of  ≥10 mm, suggestive of exposure to environmental Mycobacterium. This group of Nigerians should be made 
to undergo further diagnostic procedures for tuberculosis at regular intervals to establish that the positive TST is due to 
development of antibodies to Mycobacterium species but not as a result of actual infection. 
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Tuberculin skin test (TST), also known as Mantoux test or 
Purified Protein Derivative (PPD) test, is one of the oldest 
screening tests carried out on the skin for diagnosis of 
tuberculosis (TB) using PPD. This test is a delayed-type 
hypersensitivity (Type IV) reaction, which is based on the 
immune response of the body to intradermal injection of PPD. 
It is a heterogeneous mixture of more than 200 mycobacterial 
antigens that are common to Mycobacterium tuberculosis 
(MTB), Mycobacterium bovis bacillus of Calmette and 
Guerin (BCG), and non-tuberculous mycobacteria (NTM) 
(Andersen et al., 2000; Asuquo et al., 2009; Gualano et al., 
2019). The TST has been in existence for more than a century 
and it is still widely used in the diagnosis of latent TB in high 
endemic places (Nayak and Acharjya, 2012; World Health 
Organization, WHO, 2018). 
Infection with MTB results in development of skin sensitivity 
to tuberculin (Reichman, 1979). Generally, this infection 
occurs when an individual inhales a droplet aerosol containing 
the Mycobacterium over a long period of time. In almost all 
infected individuals, the tuberculin test elicits a measurable 
reaction (Reichman, 1979). The Centres for Disease Control 
and Prevention (CDC) identified 3 cut-off levels for positive 
TST reactions and defined them as follow: (1) An induration 
of ≥5 mm is considered positive in HIV-infected person, 
recent contacts of TB case patients, fibrotic changes on chest 
radiograph consistent with prior TB, patients with organ 
transplants and other immunosuppressed patients receiving 
the equivalent of >15 mg/d of prednisone for 1 month or more. 
(2) An induration of ≥10 mm is considered positive in recent 
immigrants (i.e., within the last 5yr) from high prevalence 
countries, injection drug users, residents and employees of 
high-risk congregate settings, Mycobacteriology laboratory 
personnel, persons with clinical conditions that place them at  
high risk, children < 4 years of age, infants, children, and 
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adolescents exposed to adults in high-risk categories. (3) An 
induration of ≥15 mm is considered positive in persons with 
no risk factors for TB (CDC, 2000). However, because of the 
low specificity and sensitivity of TST, TB may need to be 
confirm with other TB screening/diagnostic tests such as chest 
radiograph, diagnostic microbiology (sputum smear/culture), 
TB blood test, which measures the patient’s immune system 
reaction to MTB and Nucleic Acid Amplification Tests 
(NAAT) also known as Genexpert test (CDC, 2005; 2009). 
 Tuberculosis associated inflammation is reported to be 
central to progression from latent TB to active TB. The MTB 
uniquely modulates fundamental inflammatory processes 
including recruitment of immune cells to the infected lung and 
production of inflammatory cytokines such as tumour necrosis 
factor-alpha (TNF-α), interleukins (ILs) -2, -6, -12, -15, -17, -
18, -23 and -27, interferon-gamma (IFN-γ) and T-helper-1 
(Th1) cells (Tomioka et al., 2011; Kaufmann and Dorhoi, 
2013). Among these cytokines, TNF-α and IFN-γ have been 
identified to be the most important agents of the anti-
mycobacterial cytokine cascade. This is as a result of the 
formation and maintenance of the granuloma that is mediated 
by TNF-α acting in synergy with IFN-γ in the activation of 
macrophages to produce effector/oxidative stress molecules 
such as inducible nitric oxide synthase (iNOS) and nitric oxide 
(˙NO) (Chan et al., 2001; Pereira-Suárez et al., 2006; Cooper 
and Khader, 2008; Kulkarni and Madrasi, 2008; Lin and 
Flynn, 2010). The ˙NO produced by iNOS in the activated 
macrophages reacts with superoxide radicals (O2˙¯) to form 
peroxynitrite (ONOO¯), which is an unstable metabolite. 
These ONOO¯ react with protein tyrosine to produce 3-
nitrotyrosine (3-NT) that are more stable end-products 
(Ischiropoulos, 1998). 
 Nigeria has been listed by WHO as an endemic TB country 
(WHO, 2019), and a high percentage of her people live in 
conditions of social deprivation, with no access to adequate 
medical care (Asuquo et al., 2009). Therefore, there is need to 
determine the occurrence of latent TB in Nigerian populations, 
especially in people working in the hospitals. This study aimed 
at investigating the relationship between TST and 
inflammatory cytokines [tumour necrosis factor-alpha (TNF-
α), interferon-gamma (IFN-γ)] and oxidative stress 
biomarkers [3-Nitrotyrosine (3-NT), inducible nitric oxide 
synthetase (iNOS)] in apparently healthy Nigerian healthcare 
workers. 
 
MATERIALS AND METHODS 
 
Ethics: The study protocol was carried out in accordance with 
the declaration of Helsinki and was approved by the joint 
University of Ibadan/University College Hospital Institutional 
Research Ethics Committee. All participants were briefed 
about the study and informed consent was obtained from each 
participant before they were enrolled into the study. 
 
Research Design, Description of Participants and Blood 
Collection: Thirty-four male and female participants who 
were researchers and who had been working in the 
laboratories for at least two years were recruited into this 
cross-sectional study from the University College Hospital, 
Ibadan, Nigeria. The inclusion criteria are: (i) age between 18 
and 65 years, (ii) non-pregnant/lactating female, (iii) 
apparently healthy participants without clinical symptoms of 
tuberculosis. Participants with malnutrition, poor living 
conditions, immunosuppressive infections such as human 
immunodeficiency virus (HIV) were excluded from the study. 
Similarly excluded from the study were participants with 
recent contact with TB patients, organ transplants, and clinical 
conditions that place them at  high risk. From each of the 
participant, 4 mL of whole blood samples were collected into 
EDTA tubes immediately after reading the tuberculin 
diameter at 72 hours. All blood samples were centrifuged at 
4000 rpm for 10 minutes to extract plasma for the 
determination of TNF-α, IFN-γ, 3-NT and iNOS. The plasma 
samples were stored at ‒20ºC until analysis. 
 
Tuberculin Skin Test (TST): This test was performed using 
5 tuberculin units (TU) PPD (BB-NCIPD Ltd, Sophia, 
Bulgaria). About 0.1 mL of the antigen was injected 
intradermally into the dorsal surface of the forearm of each 
participant using a disposable tuberculin syringe. The results 
were evaluated 72 hours later and the diameters of the 
indurated areas were recorded in millimetres. A transverse 
induration of <5 mm was considered to be negative (non-
reactive to tuberculin antigen), between 5 and 9 mm was 
considered positive for those who had contact with TB 
patients within the last five years, between 10-14 mm was 
considered positive for healthcare workers and ≥15 mm was 
considered positive for persons with high risk for TB (CDC, 
2000). All the participants had been vaccinated with BCG 
during childhood as part of the mandatory Nigerian National 
Vaccination Program.  
 
Determination of plasma TNF-α and IFN-γ: The plasma 
samples were prepared according to the manufacturer’s 
protocol (Abcam Inc. USA). The principle involved the use of 
a pre-coated wells of the microtiter strips with a monoclonal 
antibody specific for either TNF-α or IFN-γ. Samples, 
including standards of known TNF-α or IFN-γ concentrations, 
control specimens or unknowns were pipetted into these wells. 
The standards or samples and a biotinylated monoclonal 
antibody specific for TNF-α or IFN-γ were simultaneously 
incubated for 3 hours at room temperature and washed. After 
washing, the enzyme Streptavidin-Horseradish Peroxidase 
(Streptavidin-HRP), that binds the biotinylated antibody was 
added, incubated for 30 minutes at room temperature and then 
washed. Tetramethylbenzidine (TMB) substrate solution was 
added, which act on the bound enzyme to induce coloured 
reaction products. This was read on spectrophotometer using 
450 nm as the primary wavelength and 620 nm as the 
reference wavelength (ELISA reader: Spectra Max Plus 384 
Molecular Devices LLC, USA). The intensity of the coloured 
products is directly proportional to the concentrations of TNF-
α or IFN-γ present in the samples.   
 
Determination of plasma iNOS and 3-NT: The iNOS and 3-
NT were determined using ELISA kit from Elabscience 
Biotechnology Inc., China and samples were prepared 
according to the manufacturer’s protocol. The technique was 
based on the principle of competitive-ELISA. In this principle, 
iNOS or 3-NT had been pre-coated on the microtiter plate 
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provided. During the reaction, iNOS or 3-NT in the samples 
or standards compete with fixed amount of iNOS or 3-NT on 
the solid phase supporter for sites on the biotinylated detection 
antibody specific for iNOS or 3-NT. Excess conjugate and 
unbound samples or standards were washed from the plate and 
Avidin conjugated to HRP were added to each microplate well 
and incubated. Then a TMB substrate solution was added to 
each well. The enzyme-substrate reaction was terminated by 
the addition of stop solution and the colour change was 
measured spectrophotometrically at a wavelength of 450 nm 
with an ELISA reader (Spectra Max Plus 384 Molecular 
Devices LLC, USA). The concentrations of iNOS or 3-NT in 
the samples were then determined by comparing the optical 
density (OD) of the samples to the standard curves.  
 
Data Analysis: All data were presented as frequency and 
percentages or Mean ± Standard Deviation (SD). The data 
were subjected to statistical analysis using Statistical Package 
for Social Sciences version 20 (IBM SPSS, Armonk, NY, 
USA). Independent T-tests with  equal variances not assumed 
and Spearman’s rho correlation were used for the analysis 





The mean age of the 34 participants was 34.65±12.08 years, 
19(55.9%) were females and 15(44.1%) were males.  The 
frequency of occurrence of tuberculin diameters revealed that 
12(35.3%) were non-reactive to tuberculin antigen (0-4 mm, 
negative); 6(17.6%) of the participants had tuberculin 
diameter between 5-9 mm while 7(20.6%) and 9(26.5%) had 
tuberculin diameters between 10-14 mm and ≥15 mm, 
respectively. Participants with indurations  ≥15mm in 
diameter belong to the mean age of 39.78±8.42 years while 
those with mean age of 27.25±9.00 years had indurations of 0-
4mm. Participants with indurations ≥15mm in diameter had 
highest TNF-α and IFN-γ levels compared with indurations of 
0-4 mm group (Table 1). In Table 2, age significantly and 






Tuberculin skin test is one of the few methods used, since the 
19th century, in detecting MTB infections and diagnosing TB  
in individuals. It is also used, as a screening tool, in 
epidemiological settings to measure the prevalence of TB 
infection in the populations (Nayak and Acharjya, 2012). 
Tuberculosis is considered as both community-acquired and 
occupational-infection disease with increasing trend in 
healthcare workers (Salehi et al., 2016). In a review of 
surveillance reports from the New York by Humphreys, 
despite a decline in TB from 3636 to 1434 in 1994 and 2002, 
respectively in the general populace, it increased from 2.5% to 
4% in healthcare workers as shown by skin testing and other 
TB assessments (Humphreys, 2007). Therefore, the need to 
investigate the relationship between TST and inflammatory 
and oxidative stress biomarkers in apparently healthy 
healthcare workers. 
 All participants in this study were vaccinated during 
childhood with BCG, which produces intermediate TST 
results. It is believed that the response to this vaccination and 
actual vaccine given at childhood might have waned off, thus 
negative TST result was expected in the present study at 
adulthood. However, this study revealed that indurations 
increased with age. This result is further buttressed with the 
positive association observed between age and TST, 
suggestive of infection exposure with increase in age. In 
addition, Nigeria is known to be an endemic country for TB, 
therefore the tuberculin sizes observed may be due to exposure 
of these participants to the environmental Mycobacterium 
species during the course of lives.  In this study, almost half 
of the study participants had indurations of ≥10 mm 
suggestive of possible tuberculosis reactivation due to 
environmental Mycobacterium species since those with  
malnutrition, poor living conditions, HIV, recent contact with 
TB patients and organ transplants were excluded. This finding 
is in agreement with the study of Asuquo et al. (2009), where 
a quarter of their control participants had tuberculin reactors 
with indurations of >10 mm. Similarly, it has been reported 
that 90% of people with indurations of 10 mm had 
Mycobacterium tuberculosis infection and the lifetime risk of 
reactivation of tuberculosis is 20% or more in such people 
(Brooks et al., 2004).
 
Table 1:  
Inflammatory cytokines and oxidative stress biomarkers according to TST  
 Tuberculin sizes    








P1 P2 P3 
Age (years) 27.25±9.00 40.67±14.33 35.57±14.21 39.78±8.42 0.074 0.197 0.004* 
TNF-α (pg/mL) 10.10±4.31 11.84±5.81 12.95±6.96 14.59±4.71 0.534 0.354 0.039* 
IFN-γ (pg/mL) 1.30±1.10 1.44±1.25 1.49±1.10 2.10±1.56 0.814 0.719 0.209 
3-NT (ng/mL) 19.19±5.53 16.23±5.36 24.77±8.17 19.80±8.38 0.300 0.142 0.853 
iNOS (pg/mL) 1181.04±946.10 880.52±103.87 1997.77±1163.45 1104.35±574.68 0.566 0.144 0.821 
*Significant at p<0.05; TST = Tuberculin skin test; TNF-α=Tumour necrosis factor-α; IFN-γ=Interferon-γ; 3-NT=3-Nitrotyrosine; iNOS = 
Inducible nitric oxide synthetase; P1 = Indurations of 0-4 mm (Negative) compared with indurations of 5-9 mm; P2 = Negative compared with 
indurations of 10-14 mm; P3 = Negative compared with indurations of ≥15 mm. 
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Table 2:  
Correlation of TST between inflammatory cytokines and oxidative 
stress biomarkers 
Parameters R - values P - values 
TST - Age  0.492* 0.003 
TST - TNF-α 0.337 0.051 
TST - IFN-γ 0.269 0.124 
TST - 3-NT -0.073 0.683 
TST - iNOS 0.096 0.589 
*Significant at p<0.05; TST = Tuberculin skin test; TNF-α=Tumour 
necrosis factor-α; IFN-γ=Interferon-γ; 3-NT=3-Nitrotyrosine; iNOS 
= Inducible nitric oxide synthetase 
 
 Purified protein derivative has been reported to stimulate 
CD4+ T-lymphocytes (Turner and Dockrell, 1996), which 
exert regulatory activity on macrophage function for bacterial 
elimination. This response is activated by IFN-γ in synergy 
with TNF-α (Cavalcanti et al., 2012). Although, some authors 
reported reduction in lymphoproliferative response stimulated 
by PPD antigen (Sanchez et al., 1994, Torres et al., 1998), a 
study by Moura and Colleagues, however reported no 
reduction in lymphoproliferative response (Moura et al., 
2004). In this present study, higher TNF-α and IFN-γ levels 
were found as the tuberculin diameter increases. This finding 
is further corroborated by the positive associations observed 
between the TST and these inflammatory cytokines. Thus, 
indicating the presence of tuberculosis stimulating antigen in 
these participants. However, 3-NT and iNOS levels were 
highest at indurations between 10 and 14 mm with no 
association between these oxidative stress biomarkers and 
TST. This finding supported the report of de Andrade et al. 
(2008), where PPD positively correlate with TNF-α.  
 In conclusion. in this study, higher levels of tumour 
necrosis factor-alpha and interferon-gamma were found as 
tuberculin diameter increases in the healthcare workers. 
Almost half of the healthcare workers had tuberculin diameter 
of indurations ≥10 mm, which may indicate higher likelihood 
of progression to active tuberculosis from latent tuberculosis. 
Therefore, it would be recommended that Nigerian healthcare 
workers be made to undergo further diagnostic procedures and 
be screened intermittently for tuberculosis. This is to establish 
that the positive tuberculin skin test is due to development of 
antibodies to Mycobacterium species but not as a result of 
actual infection. Also, fruit and vegetables, which can help in 
boosting the immune system, be included in the daily diet of 
all healthcare workers.  
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